Form Type: 4

SEC EDGAR Link
Accession Number:0001062993-21-002790
Date:2021-03-16
Issuer: BRICKELL BIOTECH, INC. (BBI)
Original Submission Date:

Reporting Person:

MCAVOY DAVID R.
C/O BRICKELL BIOTECH, INC.
5777 CENTRAL AVENUE, SUITE 102 BOULDER, CO 80301

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-03-16 M 25,000 a $0.00 100,883 direct
COMMON STOCK 2021-03-16 F 8,750 d $1.14 92,133 direct
COMMON STOCK 0 $0.00 6,000 indirect
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
RESTRICTED STOCK UNITS 0.0 2021-03-16 deemed execution date M 25,000 (d) common stock 25,000 $0.00 0 direct
Footnotes
IDfootnote
f1 restricted stock units ("rsus") converted into common stock on a one-for-one basis.
f2 represents shares withheld to satisfy tax withholding obligations upon the vesting of rsus.
f3 these rsus vested in full on march 16, 2021.

Elevate your investments